Dotacje
Wszystkie dotacje
22,225 wyników · strona 132 z 1112
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)15 Oct 2027pozostało 373 dni
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)15 Oct 2027pozostało 373 dni
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)15 Oct 2027pozostało 373 dni
- Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)15 Oct 2027pozostało 373 dni
- NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)16 Oct 2027pozostało 374 dni
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)18 Oct 2027pozostało 376 dni
- Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)19 Oct 2027pozostało 377 dniUS$650,000
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)19 Oct 2027pozostało 377 dniUS$2,400,000
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)20 Oct 2027pozostało 378 dniUS$750,000
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)20 Oct 2027pozostało 378 dniUS$750,000
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)20 Oct 2027pozostało 378 dni
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)25 Oct 2027pozostało 383 dni
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)25 Oct 2027pozostało 383 dni
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)25 Oct 2027pozostało 383 dni
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)25 Oct 2027pozostało 383 dni
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)25 Oct 2027pozostało 383 dni
- SACCCT – Projetos de Ciência de Contexto Europeu27 Oct 2027pozostało 386 dni€2,000,000
- Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)28 Oct 2027pozostało 386 dni
- Regione Valle d'Aosta - Avviso per la concessione di incentivi alle imprese per l’inserimento di persone con disabilità - Anno 2026-202729 Oct 2027pozostało 387 dni€300,000
- PASS Transitions30 Oct 2027pozostało 388 dni